Fast Facts: Biosimilars in Hematology and Oncology

Biologics and biosimilars - getting decisions right

Paul Cornes, Ali McBride (Autoren)

Buch | Softcover

128 Seiten

2020
S. Karger Publishers Ltd (Verlag)
978-1-912776-21-4 (ISBN)

Infos

Biologics have revolutionized - and are revolutionizing - the treatment of many serious disorders. The evidence acquired from more than 10 years of clinical experience, with more than 50 biosimilar drugs and more than 700 million patient-days' exposure in Europe, shows that approved biosimilars can be used as safely and effectively as originator biologics. Yet concerns persist about biosimilars - particularly in curative cancer treatment, where they are relatively recent therapeutic options. 'Fast Facts: Biosimilars in Hematology and Oncology' provides a concise overview of emerging global practice in this fast-moving area together with practical information on adding biosimilars to a formulary and switching patients. Contents: * Biologics and the need for biosimilars * Why do we need biosimilars? * How is the quality of biosimilar medicines assured? * Legal issues * Switching, interchangeability and extrapolation * Safety and pharmacovigilant * Global issues * Formulary considerations: pharmacy issues * Formulary considerations: supportive care biosimilars * Formulary considerations: therapeutic anti-cancer biosimilars * Communication and awareness

Produkt-Details

• Erscheinungsdatum: 28.01.2020
• Zusatzinfo: 17 fig., 16 in color, 27 tab.
• Verlagsort: Basel
• Sprache: englisch
• Maße: 148 x 210 mm
• Gewicht: 220 g
• Themenwelt: Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie
• Schlagworte: Chemotherapy
• ISBN-10: 1-912776-21-9 / 1912776219
• ISBN-13: 978-1-912776-21-4 / 9781912776214
• Zustand: Neuware